Ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11
Phytomedicine · 2023-05 · 113 · 154681
DOI: 10.1016/j.phymed.2023.154681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2023-05. Verfasst von Jian Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People's Republic of China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Ferroptosis, Myocardial Ischemia, Reperfusion Injury. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Ginsenoside Re is an active component in ginseng that confers protection against myocardial ischemia/reperfusion (I/R) injury. Ferroptosis is a type of regulated cell death found in various diseases. PURPOSE: Our study aims to investigate the role of ferroptosis and the protective mechanism of Ginsenoside Re in myocardial ischemia/reperfusion. METHODS: In the present study, we treated rats for five days with Ginsenoside Re, then established the myocardial ischemia/reperfusion injury rat model to detect molecular implications in myocardial ischemia/reperfusion regulation and to determine the underlying mechanism. RESULTS: This study identifies the mechanism behind ginsenoside Re's effect on myocardial ischemia/reperfusion injury and its regulation of ferroptosis through miR-144-3p. Ginsenoside Re significantly reduced cardiac damage caused by ferroptosis during myocardial ischemia/reperfusion injury and glutathione decline. To determine how Ginsenoside Re regulated ferroptosis, we isolated exosomes from VEGFR2+ endothelial progenitor cells after ischemia/reperfusion injury and performed miRNA profiling to screen the miRNAs aberrantly expressed in the process of myocardial ischemia/reperfusion injury and ginsenoside Re treatment. We identified that miR-144-3p was upregulated in myocardial ischemia/reperfusion injury by luciferase report and qRT-PCR. We further confirmed that the solute carrier family 7 member 11 (SLC7A11) was the target gene of miR-144-3p by database analysis and western blot. In comparison with ferropstatin-1, a ferroptosis inhibitor, in vivo studies confirmed that ferropstatin-1 also diminished myocardial ischemia/reperfusion injury induced cardiac function damage. CONCLUSION: We demonstrated that ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People's Republic of China.
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People's Republic of China; Department of Cardiology, Shanghai Putuo Central School of Clinical Medicine, A…
- Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, People's Republic of China. Electronic address: kevingjq@sina.com.
Zitieren
APA
Ye, J., Lyu, T. J., Li, L. Y., Liu, Y., Zhang, H., Wang, X., Xi, X., Liu, Z. J., & Gao, J. Q. (2023). Ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11. Phytomedicine, 113, 154681. https://doi.org/10.1016/j.phymed.2023.154681
Vancouver
Ye J, Lyu TJ, Li LY, Liu Y, Zhang H, Wang X, et al. Ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11. Phytomedicine. 2023;113:154681. doi:10.1016/j.phymed.2023.154681
BibTeX
@article{Ye2023,
author = {Ye, Jian and Lyu, Tian-Jiao and Li, Ling-Yan and Liu, Ying and Zhang, Hong and Wang, Xu and Xi, Xin and Liu, Zong-Jun and Gao, Jun-Qing},
title = {Ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11},
journal = {Phytomedicine},
year = {2023},
volume = {113},
pages = {154681},
doi = {10.1016/j.phymed.2023.154681}
}
EUVIMED